跳至主要内容
临床试验/NL-OMON37801
NL-OMON37801已完成4 期

Cross-sectional study of 24-hours blood pressure measures and left ventricular mass using echocardiograms in late adolescents and adults with ADHD. - ADDUCE: blood pressure and left ventrikel mass in ADHD.

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 320 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational invasive

入排标准

年龄范围
12 至 99(—)

入选标准

  • Target group:
  • Patients with ADHD according to DSM-IV criteria (any subtype), based on clinical diagnosis, and confirmed by a structured interview [depending on local procedures: ADHD module of the K-SADS (Kaufman et al., 2000) or CAADID (Conners Adult ADHD Diagnostic Interview for DSM-IV) (www.mhs.com/) or DIVA (Diagnostic Interview for Adult ADHD) (www.divacenter.eu/Content/Downloads/DIVA_2.pdf).
  • Aged between 15 and 25 years.
  • Any comorbidity is allowed.
  • Any comedication is allowed.
  • Treated with methylphenidate (IR or ER preparations) for 3 years or longer, continuously.;Note: we will attempt to recruit at least 50% of the participants of the target group being treated continuously for 3 years with a minimum effective dose of 0.5 mg methylphenidate /kg/day). Being treated continuously means being prescribed methylphenidate continuously but may include the presence of drug holidays. We will measure adherence by asking questions about drug holidays and % of the overall dose taken. We will allow for some variation in dosages prescribed to be able to analyze dose-response relationships.;Control group:
  • Patients with ADHD according to DSM*IV criteria (any subtype), based on clinical diagnosis.
  • Aged between 15 and 25 years.
  • Any comorbidity is allowed.
  • Any comedication is allowed.
  • Never been treated with methylphenidate.

排除标准

  • All Groups: Treatment with dexamfetamine or atomoxetine.
  • ADHD controls: Treatment with methylphenidate.

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验